Benzinga - by Benzinga Insights, Benzinga Staff Writer. Abbott Laboratories's (NYSE:ABT) short percent of float has risen 22.81% since its last report. The company recently...
Benzinga - by Benzinga Insights, Benzinga Staff Writer. Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.04% on an annualized basis producing...
Benzinga - by Lisa Levin, Benzinga Editor. On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc. (NYSE: VSH) is "way too cheap." He added,...
Amid rising concerns that advanced diabetic treatments could reduce the need for blood glucose monitoring devices, recent financial reports indicate a contrasting trend. Companies...
NEW YORK - Bristol Myers (NYSE:BMY) Squibb Co. (NYSE:BMY) experienced a downturn on Thursday, ending a two-day streak of gains as its shares dropped 1.42% to close at $50.84. The...
Institutional investors continue to exercise significant influence over Abbott Laboratories (NYSE:ABT) due to their substantial ownership of approximately 76% of the company's...
Pfizer Inc. (NYSE:PFE)'s shares experienced a marginal increase of 0.03% to $30.56 on Tuesday, marking the second day of consecutive gains in a favorable market environment....
(Updated - November 13, 2023 2:32 PM EST) Penumbra, Inc. (NYSE:PEN) and other medical device stocks gained on Monday. The move higher was tied to new Wegovy data from Novo Nordisk...
Abbott (ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool...
Benzinga - by Lisa Levin, Benzinga Editor. The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell...